TENET HEALTHCARE CORP (THC)

Services-General Medical & Surgical Hospitals, NEC · market cap $20.9B · as of 2026-07-10

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst

None scheduled

Pipeline

programs

Upcoming events

next 90d+

Dossier

Ready

cached

Tenet Healthcare Corporation (THC) is a Dallas-based for-profit hospital and healthcare services operator with ~65 hospitals, 450+ facilities, and nearly 98,000 employees. The company generates over $21B in annual revenue through its hospital segment, USPI ambulatory surgery platform, and Conifer Health Solutions business. An upcoming Q2 2026 earnings print on July 24 is the primary near-term catalyst.

The catalyst path

No upcoming catalysts in our calendar.

Pipeline

Asset	Phase	Indication
VB119	Phase 2	Membranous Nephropathy

Price & technical context

3-month

+40.5%

6-month

+28.7%

12-month

+32.4%

52-wk range

$161.37–$280.77

vs 50-day MA

+1.4%

vs 200-day MA

+21.5%

Realized vol

42.1%

Max drawdown

-34.5%

Daily closes through 2026-09-23. Realized vol annualized; max drawdown over ~2 years.

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.

Sources & data

SEC filings — EDGAR filings for THC (10-K, 10-Q, S-3, 13D/G, Form 4)
Clinical trials — 1 registered trial on ClinicalTrials.gov (per-trial NCT links in the pipeline)
Market & financial data — SEC EDGAR (XBRL filings, Form 4), Yahoo Finance, Nasdaq — prices, statements, key metrics, insider & institutional filings.
Regulatory — openFDA, FDA advisory & PDUFA calendars.

Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, market-data providers). Compiled by CeliA. Not financial advice.